Company intelligence / Profile preview

NovoSere

Ownership: Private
Development stage: Other

Overview

NovoSere is a consultancy firm specializing in pharmaceutical Chemistry, Manufacturing and Control (CMC), offering development services for early-stage drug development. The team brings deep expertise in advanced drug delivery, biotechnology, non-biological complex formulations, injectables, GMP manufacturing, tech transfer, QbD (Quality by Design), project management and analytical chemistry. They support clients through all stages of CMC development but do not have their own clinical programs or products

Therapeutic areas: Other
Modalities: Small moleculeBiologicNon-biological complex formulationsInjectables
Industry: Drug Discovery Services

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed as of June 2025.

Beyond the preview

Go deeper on NovoSere.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NovoSere.

Explore the full profile